Xpreza 100mg Azacitidine Injection

Xpreza 100mg Azacitidine Injection is a prescription anti-cancer medication used in the treatment of myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and certain other bone marrow disorders. It contains Azacitidine, a hypomethylating agent that works by restoring normal gene activity and slowing the growth of abnormal blood cells in the bone marrow. By improving blood cell production, Xpreza 100mg Azacitidine Injection can help reduce transfusion requirements and support better disease management. Administered as a subcutaneous or intravenous injection under the supervision of a healthcare professional, it requires regular monitoring of blood counts and overall health throughout treatment. Patients should use Xpreza 100mg Azacitidine Injection only as prescribed by their healthcare provider and follow all recommended medical appointments.